N-((5-(4-Fluorophenyl)isoxazol-3-yl)methyl)-5-methylisoxazole-3-carboxamide

Catalog No.: 
ACAIIS913
CAS No.: 
1208844-79-4
Molecular Formula: 
C15H12FN3O3
Molecular Weight: 
301.28
N-((5-(4-Fluorophenyl)isoxazol-3-yl)methyl)-5-methylisoxazole-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((5-(4-Fluorophenyl)isoxazol-3-yl)methyl)-5-methylisoxazole-3-carboxamide
IUPAC NameN-((5-(4-fluorophenyl)isoxazol-3-yl)methyl)-5-methylisoxazole-3-carboxamide
Molecular FormulaC15H12FN3O3
Molecular Weight301.28
SMILESO=C(C1=NOC(C)=C1)NCC2=NOC(C3=CC=C(F)C=C3)=C2
InChI KeyCNTKFANCORTNFS-UHFFFAOYSA-N
Synonym3-Isoxazolecarboxamide, N-[[5-(4-fluorophenyl)-3-isoxazolyl]methyl]-5-methyl-
CAS No.1208844-79-4

Synthetic Route by SureRoute

1. ACAIIS913 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQDTS764 route compound structure diagram
    ACQDTS7643405-77-4In Stock
  2. Plus
  3. ACGBXI250 route compound structure diagram
    ACGBXI2501327645-29-3In Stock
  4. Then
  5. ACAIIS913 route product structure diagram
    ACAIIS9131208844-79-4
Inquiry

2. ACAIIS913 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRXH568 route compound structure diagram
    ACLRXH56839499-34-8In Stock
  2. Plus
  3. ACGBXI250 route compound structure diagram
    ACGBXI2501327645-29-3In Stock
  4. Then
  5. ACAIIS913 route product structure diagram
    ACAIIS9131208844-79-4
Inquiry

3. ACAIIS913 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACASXU801 route compound structure diagram
    ACASXU8013209-72-1In Stock
  2. Plus
  3. ACGBXI250 route compound structure diagram
    ACGBXI2501327645-29-3In Stock
  4. Then
  5. ACAIIS913 route product structure diagram
    ACAIIS9131208844-79-4
Inquiry

Comments (0)